WHO ICTRP trial
Parathyroid hormone in the recovery from hip fractures: a pilot study
ISRCTN03362357 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN03362357 |
|---|---|
| Public title | Parathyroid hormone in the recovery from hip fractures: a pilot study |
| Scientific title | The administration of intermittent parathyroid hormone affects functional recovery from pertrochanteric fractured neck of femur: a prospective mixed method pilot study with randomisation of treatment allocation and blinded assessment |
| Primary sponsor | North Bristol NHS Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Hip fractures Injury, Occupational Diseases, Poisoning Hip fracture |
| Interventions | Intervention: tereparatide (Forsteo®) 20 µg/day injections Comparator: standard care Total duration of treatment: 6 weeks Total duration of follow up: 6 months Subjects participating in nested qualitative study will be followed for 12… |
| Registration date | Mar 3, 2011 |
| Target size | 40 |
| Secondary IDs | R&D 2185 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: